These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22524658)

  • 1. CXCR7: a novel tumor endothelial marker in renal cell carcinoma.
    Maishi N; Ohga N; Hida Y; Akiyama K; Kitayama K; Osawa T; Onodera Y; Shinohara N; Nonomura K; Shindoh M; Hida K
    Pathol Int; 2012 May; 62(5):309-17. PubMed ID: 22524658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
    Yamada K; Maishi N; Akiyama K; Towfik Alam M; Ohga N; Kawamoto T; Shindoh M; Takahashi N; Kamiyama T; Hida Y; Taketomi A; Hida K
    Int J Cancer; 2015 Dec; 137(12):2825-36. PubMed ID: 26100110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The F-prostaglandin receptor is a novel marker for tumor endothelial cells in renal cell carcinoma.
    Akiyama K; Ohga N; Maishi N; Hida Y; Kitayama K; Kawamoto T; Osawa T; Suzuki Y; Shinohara N; Nonomura K; Shindoh M; Hida K
    Pathol Int; 2013 Jan; 63(1):37-44. PubMed ID: 23356224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between endothelial CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma.
    Yanagiya M; Dawood RIH; Maishi N; Hida Y; Torii C; Annan DA; Kikuchi H; Yanagawa Matsuda A; Kitamura T; Ohiro Y; Shindoh M; Tanaka S; Kitagawa Y; Hida K
    Pathol Int; 2021 Jun; 71(6):383-391. PubMed ID: 33783897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SDF-1/CXCR7 axis regulates the proliferation, invasion, adhesion, and angiogenesis of gastric cancer cells.
    Ma DM; Luo DX; Zhang J
    World J Surg Oncol; 2016 Oct; 14(1):256. PubMed ID: 27716367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells.
    Yamamoto K; Ohga N; Hida Y; Maishi N; Kawamoto T; Kitayama K; Akiyama K; Osawa T; Kondoh M; Matsuda K; Onodera Y; Fujie M; Kaga K; Hirano S; Shinohara N; Shindoh M; Hida K
    Br J Cancer; 2012 Mar; 106(6):1214-23. PubMed ID: 22374465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR7 silencing inhibits the migration and invasion of human tumor endothelial cells derived from hepatocellular carcinoma by suppressing STAT3.
    Wu Y; Tian L; Xu Y; Zhang M; Xiang S; Zhao J; Wang Z
    Mol Med Rep; 2018 Aug; 18(2):1644-1650. PubMed ID: 29901083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MicroRNA-218 on the viability, apoptosis and invasion of renal cell carcinoma cells under hypoxia by targeted downregulation of CXCR7 expression.
    Zhang S; Hong Z; Li Q; Lei J; Huang H; Liu Q
    Biomed Pharmacother; 2016 May; 80():213-219. PubMed ID: 27133059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.
    Edeline J; Mottier S; Vigneau C; Jouan F; Perrin C; Zerrouki S; Fergelot P; Patard JJ; Rioux-Leclercq N
    Hum Pathol; 2012 Nov; 43(11):1982-90. PubMed ID: 22626276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and promotes tumor cell survival through ERK activation.
    Hu SC; Yu HS; Yen FL; Chen GS; Lan CC
    Exp Dermatol; 2014 Dec; 23(12):902-8. PubMed ID: 25256412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels.
    Schmid MC; Bisoffi M; Wetterwald A; Gautschi E; Thalmann GN; Mitola S; Bussolino F; Cecchini MG
    Int J Cancer; 2003 Feb; 103(5):577-86. PubMed ID: 12494464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells.
    Otsubo T; Hida Y; Ohga N; Sato H; Kai T; Matsuki Y; Takasu H; Akiyama K; Maishi N; Kawamoto T; Shinohara N; Nonomura K; Hida K
    Cancer Sci; 2014 May; 105(5):560-7. PubMed ID: 24602018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.
    Zhang H; Yang L; Teng X; Liu Z; Liu C; Zhang L; Liu Z
    Tumour Biol; 2016 Feb; 37(2):2415-23. PubMed ID: 26383519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.
    Gahan JC; Gosalbez M; Yates T; Young EE; Escudero DO; Chi A; Garcia-Roig M; Satyanarayana R; Soloway MS; Bird VG; Lokeshwar VB
    J Urol; 2012 Mar; 187(3):827-33. PubMed ID: 22245330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.
    D'Alterio C; Consales C; Polimeno M; Franco R; Cindolo L; Portella L; Cioffi M; Calemma R; Marra L; Claudio L; Perdonà S; Pignata S; Facchini G; Cartenì G; Longo N; Pucci L; Ottaiano A; Costantini S; Castello G; Scala S
    Curr Cancer Drug Targets; 2010 Nov; 10(7):772-81. PubMed ID: 20578990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1α-induced gene expression, invasion and chemosensitivity of colon cancer.
    Heckmann D; Maier P; Laufs S; Li L; Sleeman JP; Trunk MJ; Leupold JH; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
    Clin Cancer Res; 2014 Feb; 20(3):604-16. PubMed ID: 24255072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
    Long P; Sun F; Ma Y; Huang Y
    Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer.
    Guo JC; Li J; Zhou L; Yang JY; Zhang ZG; Liang ZY; Zhou WX; You L; Zhang TP; Zhao YP
    Oncotarget; 2016 Sep; 7(38):62006-62018. PubMed ID: 27542220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.